Corient Capital Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $422K | Hold |
8,436
| – | – | 0.03% | 376 |
|
|
2022
Q2 | $422K | Sell |
8,436
-7
| -0.1% | -$350 | 0.03% | 386 |
|
|
2022
Q1 | $433K | Buy |
8,443
+668
| +9% | +$34.3K | 0.03% | 416 |
|
|
2021
Q4 | $390K | Buy |
7,775
+2,655
| +52% | +$133K | 0.03% | 435 |
|
|
2021
Q3 | $247K | Buy |
5,120
+128
| +3% | +$6.18K | 0.02% | 563 |
|
|
2021
Q2 | $263K | Buy |
+4,992
| New | +$263K | 0.02% | 529 |
|
|
2020
Q4 | – | Sell |
-4,946
| Closed | -$248K | – | 557 |
|
|
2020
Q3 | $248K | Buy |
4,946
+19
| +0.4% | +$953 | 0.03% | 386 |
|
|
2020
Q2 | $252K | Sell |
4,927
-461
| -9% | -$23.6K | 0.03% | 379 |
|
|
2020
Q1 | $236K | Sell |
5,388
-1,312
| -20% | -$57.5K | 0.04% | 335 |
|
|
2019
Q4 | $336K | Buy |
6,700
+661
| +11% | +$33.1K | 0.04% | 336 |
|
|
2019
Q3 | $280K | Buy |
+6,039
| New | +$280K | 0.04% | 353 |
|